BioStat Solutions, Inc is a leading authority in the identification, development and validation of biomarkers to predict patient response to treatment on efficacy and toxicity outcomes.

As pharmaceutical companies attempt to integrate a patient’s genetic profile into the therapeutic decision making process, BioStat Solutions, Inc has been at the forefront of personalized medicine as a contributing participant of the Industry Pharmacogenomics Working Group and a member of the Personalized Medicine Coalition.

PGx Study Design

Careful planning produces meaningful results that can address both your clinical and business objectives. We foster interdisciplinary communication with clinicians, statisticians, geneticists, biologists and executives in order to develop a design that is efficient and robust to your needs.

Analyzing Biomarkers

BioStat Solutions, Inc’s team is adept at analyzing SNPs, haplotypes and gene expression profiles for correlation with drug efficacy and toxicity. We are experienced in the application of both whole genome and candidate gene approaches in understanding the impact of genetic variation on drug response.